Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Gains from Investment Securities: 2018-2025

Historic Gains from Investment Securities for Evolus (EOLS) over the last 8 years, with Sep 2025 value amounting to -$107,000.

  • Evolus' Gains from Investment Securities fell 104.41% to -$107,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$305,000, marking a year-over-year decrease of 106.06%. This contributed to the annual value of $7.2 million for FY2024, which is 57.71% up from last year.
  • As of Q3 2025, Evolus' Gains from Investment Securities stood at -$107,000, which was up 97.27% from -$3.9 million recorded in Q2 2025.
  • In the past 5 years, Evolus' Gains from Investment Securities registered a high of $2.4 million during Q3 2024, and its lowest value of -$3.9 million during Q2 2025.
  • Its 3-year average for Gains from Investment Securities is $896,000, with a median of $1.6 million in 2024.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first soared by 368.90% in 2024, then tumbled by 343.86% in 2025.
  • Evolus' Gains from Investment Securities (Quarterly) stood at $2.2 million in 2021, then fell by 19.28% to $1.8 million in 2022, then plummeted by 132.17% to -$582,000 in 2023, then skyrocketed by 368.90% to $1.6 million in 2024, then crashed by 104.41% to -$107,000 in 2025.
  • Its last three reported values are -$107,000 in Q3 2025, -$3.9 million for Q2 2025, and $2.2 million during Q1 2025.